menu
    • menu

    Company profile for PsychoGenics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PsychoGenics has built a vibrant contract research business based on high-capacity and high-quality testing with fast turnaround and delivery of results. Since our founding in 1999 we have performed tens of thousands of studies for hundreds of clients averaging 350 studies per year. Over 90 percent of our clients return for repeat business, attesting to the quality of service provided. Through our journey, our team of talen...
    PsychoGenics has built a vibrant contract research business based on high-capacity and high-quality testing with fast turnaround and delivery of results. Since our founding in 1999 we have performed tens of thousands of studies for hundreds of clients averaging 350 studies per year. Over 90 percent of our clients return for repeat business, attesting to the quality of service provided. Through our journey, our team of talented scientists have developed innovative AI-driven drug discovery platforms and analytical tools leading to shared-risk partnerships and numerous drug candidates in clinical trials.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PsychoGenicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    215 College Road, Paramus, NJ 07652
    Telephone
    Telephone
    (914) 406-8019
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.psychogenics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cassava Sciences touts positive preclinical study on Simufilam
    Cassava Sciences touts positive preclinical study on Simufilam

    04 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/04/3126466/8339/en/Cassava-Sciences-Reports-Positive-Preclinical-Study-Evaluating-Simufilam-for-TSC-Related-Epilepsy.html

    GLOBENEWSWIRE
    04 Aug 2025
    Share Share
    PsychoGenics Awarded NIH Contract For Pain Therapeutics
    PsychoGenics Awarded NIH Contract For Pain Therapeutics

    08 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241008352942/en

    BUSINESSWIRE
    08 Oct 2024
    Share Share
    PsychoGenics Awarded $3M Grant For Rare Disorder Treatments
    PsychoGenics Awarded $3M Grant For Rare Disorder Treatments

    28 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240828625678/en

    BUSINESSWIRE
    28 Aug 2024
    Share Share
    PsychoGenics Announces Exclusive Global License for an IND-Ready ENT1 Inhibitor
    PsychoGenics Announces Exclusive Global License for an IND-Ready ENT1 Inhibitor

    01 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231201150468/en

    BUSINESSWIRE
    01 Dec 2023
    Share Share
    PsychoGenics Launches an Updated Corporate Identity and Brand
    PsychoGenics Launches an Updated Corporate Identity and Brand

    10 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231110681281/en

    BUSINESSWIRE
    10 Nov 2023
    Share Share
    PsychoGenics and Collaborations Pharmaceuticals awarded a $1M grant
    PsychoGenics and Collaborations Pharmaceuticals awarded a $1M grant

    05 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230905116595/en

    BUSINESSWIRE
    05 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search